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Background: Mammalian genes are regulated through the action of multiple regulatory elements, often distributed
across large regions. The mechanisms that control the integration of these diverse inputs into specific gene
expression patterns are still poorly understood. New approaches enabling the dissection of these mechanisms
in vivo are needed.
Results: Here, we describe TRACER (http://tracerdatabase.embl.de), a resource that centralizes information from a
large on-going functional exploration of the mouse genome with different transposon-associated regulatory
sensors. Hundreds of insertions have been mapped to specific genomic positions, and their corresponding
regulatory potential has been documented by analysis of the expression of the reporter sensor gene in mouse
embryos. The data can be easily accessed and provides information on the regulatory activities present in a large
number of genomic regions, notably in gene-poor intervals that have been associated with human diseases.
Conclusions: TRACER data enables comparisons with the expression pattern of neighbouring genes, activity of
surrounding regulatory elements or with other genomic features, revealing the underlying regulatory architecture
of these loci. TRACER mouse lines can also be requested for in vivo transposition and chromosomal engineering, to
analyse further regions of interest.
Keywords: Gene regulation and expression, Genome organisation, Regulatory landscapes, Chromosomal
engineering, Mouse models of human structural variationBackground
Genes occupy only a small fraction of mammalian ge-
nomes. Accordingly, intergenic regions can extend up to
several megabases, and the functional importance of
these regions is being growingly recognized [1] (Figure 1).
Notably, these regions comprise important elements that
control gene expression [3]. Enhancer elements are
frequently found hundreds of kilobases away from the
promoter of the gene they control, sometimes even sepa-
rated from it by unrelated genes [4-11]. These remote
enhancers can be essential for gene expression, as shown
by human disorders resulting from their mutation or
disruption by chromosomal rearrangements [12-16]. The* Correspondence: damian@ebi.ac.uk; spitz@embl.de
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reproduction in any medium, provided the orimportance of these intergenic regions in human pheno-
typic diversity and disease susceptibility is further em-
phasized by the significant proportion of risk alleles that
have been identified in gene-desert intervals [3,17-20].
Thus, there is a pressing need to better characterize the
nature of the regulatory activities embedded in such
regions and to obtain animal models to help dissect
in vivo how variations in these regions contribute to
human phenotypes.
Recent progress in whole genome chromatin profiling
has led to the identification of chromatin features that
are strongly correlated with gene regulatory elements
[21-26], opening ways to obtain a comprehensive cata-
logue of these elements, and a better annotation of the
regulatory genome [27]. Databases that document the
in vivo activities of experimentally validated regulatory
elements – mostly enhancers – further complement
these approaches [28]. Such datasets on regulatory
activity can be compared to gene expression data intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Genome organisation and TRACER. (A) Schematic representation of a genomic locus, with the different elements that control gene
expression, and the specialized databases dedicated to their description (see Websites). The TRACER database displays information from a
regulatory sensor that detects the regulatory influences active at its insertion site, outlining the characteristics and extent of genomic regulatory
landscapes. (B) The GROMIT strategy. A transposon that contains the regulatory sensor can be remobilised in vivo from its start site by a
transposase transgene (not shown) active only in the male germline [2]. The genomic position of the new insertions and the associated
expression pattern defined by LacZ staining in mouse embryos is displayed in the TRACER database.
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http://www.biomedcentral.com/1471-2164/14/215developing mouse embryos [29-35]. However one can-
not reduce gene expression to a catalogue of the many
potential regulatory elements present in the genome
(from few hundred thousands to millions [22]). It is
equally important to understand the interplay between
the different elements present at a locus and how their
different inputs are integrated and conveyed to target
gene(s). Yet, compared to enhancers, other cis-regulatory
elements such as silencers are much more elusive, des-
pite their essential role in gene expression. Similarly im-
portant are the mechanisms that define the range and
specificity of enhancer-promoter interactions. Indeed,
changes in the relative position of genes and regulatory
elements by chromosomal rearrangements and struc-
tural variations can alter gene expression with dramatic
consequences [36-40]. Understanding these situations
and the associated mechanisms requires approaches that
complement the available catalogues of elements andprovide a functional integrated view of the genome regu-
latory architecture.
For this purpose, we have developed an approach
based on the distribution of a regulatory sensor gene
throughout the mouse genome [2] (Figure 1B). The
regulatory sensor consists of a LacZ reporter gene,
which is driven by a minimal promoter that has no spe-
cific activity on its own but responds faithfully to en-
dogenous enhancers. This regulatory sensor therefore
uncovers the regulatory potential associated with a given
genomic position, which results from the collective
action of the different regulatory elements that act on
this position. It thus reveals, in an operational manner,
the gene regulatory activities within poorly characterized
regions, or where annotation for activity is indirect
(eg. chromatin profiling) or out of the proper genomic
context (eg. transgenic assays). Importantly, the minimal
promoter used does not display any obvious tissue- or
Figure 2 The different transposons used in TRACER. Within the
left and right inverted/direct repeats of the SB transposon (black
double arrows) different cargoes have been cloned that can be
utilised for various purposes. Most lines contain an insertion of either
the SB9 or SB8 transposon, comprising a LacZ reporter gene with a
SV40 polyA sequence (blue rectangle), driven by a synthetic
promoter composed of 50 bp of the human beta-globin promoter
(black box with β), and a loxP site (red triangle). Newer transposons
with additional features have been constructed, and mice with these
transposons are being produced. Additional modules comprise sites
for the PhiC31 integrase (attB), and the I-Sce1 meganuclease, which
open possibilities to use the transposon as a docking site for
incoming cassettes [46-48]. TetO binding sites can be used to recruit
fusion proteins [49]. SBIL contains an insulator/enhancer-blocker
element (Ins, orange block, from the chicken HSS4 element [50])
flanked by loxP and lox2272 (white triangle with red contour).
Cre-mediated recombination can transform this transposon into
different derivatives (SBL or SB2lox), depending on which lox sites
are used.
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often overlap with the ones of neighbouring genes [2].
The basic principle of the strategy is analogous to an
enhancer-trap [41]; however, the sensor used in our ap-
proach has minimal impact on endogenous gene expres-
sion [2] and therefore reveals regulatory activities without
titrating them away from their natural target genes.
This regulatory sensor is carried in a Sleeping Beauty
transposon, which can be distributed randomly in the
mouse genome, by remobilisation in the male germline
[2]. Owing to the efficiency of this in vivo transposition sys-
tem, we have recovered, identified and characterized a large
number of insertions that provide a direct view of the regu-
latory activities associated with specific genomic regions.
Furthermore, as the transposons used also carry a loxP site,
the different lines can be used for in vivo chromosomal en-
gineering, to generate mice with targeted deletions or dupli-
cations, or segmental aneuploidies [2,42-44]. The local
hopping behaviour of Sleeping Beauty makes each line a
potential starting point to scan a region of interest [45]:
with our germline-specific transposase transgene, the
remobilization rate ranges from 10 to 45%, depending on
the starting site, and more than 15% of new insertions are
within 1 Mb of the starting point. Thus, a research group
with access to a limited number of cages can nonetheless
set up a regional screen for its region of interest.
To provide a simple and useful access to the expres-
sion patterns and the mouse insertion strains generated
with this on-going project, we have designed the
Transposon- and Recombinase-Associated Chromo-
somal Engineering Resource (TRACER) database. This
new database is freely accessible at http://tracerdatabase.
embl.de/. It constitutes a substantial improvement over
the previous one that was established to display the data
from a limited pilot screen [2]. The new database com-
prises novel features that allow users to browse and per-
form refined searches of insertion sites by position and/
or expression patterns. The dataset is also now much
larger (4-fold increase, with about 1500 insertions in July
2012), and is growing steadily. This web-based database
not only provides information on regulatory activities
present along the mouse genome but also gives access to
a large collection of mice for engineering chromosomal
rearrangements in non-genic intervals.
Construction and content
Dataset
In July 2012, the TRACER database contained informa-
tion on 1467 insertions, 643 of which had been charac-
terized for expression in mouse embryos (mostly at
stage E11.5). Specific expression patterns were reported
for 344 insertions, documented and annotated by 852
pictures. The dataset is updated regularly, with new in-
sertions and new expression data. Most insertions wereobtained with SB9 or SB8 transposons, which contain
the regulatory sensor and a loxP site cloned in one or
the other orientation in the Sleeping Beauty transposon.
Newer versions of the transposon with additional fea-
tures have been developed (Figure 2) and will be intro-
duced in the database when mice with such insertions
will be available.
Methodology and population of database
All our data is stored on a MySQL 5.5.15 RDBMS
community server (GPL). Server side programming lan-
guages are PHP and PERL CGI. CSS and the javascript
framework jQuery render the client data display and
graphical user interfaces.
As well as the external user interfaces described below,
the TRACER database has internal interfaces restricted
to contributing members and requiring login for authen-
tication. These internal interfaces have all the LIMS (la-
boratory information management system) components
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ous administration purposes.
The main internal interface allows lab staff to add all
the text annotation, and insert sequence and image files
associated with a particular TRACER line. There is also
a batch upload interface for multiple insert sequences.
The backend code automatically cuts the sequence down
to just the insert, verifies the mutagen tag is present and
the genomic sequence starts with ‘TA’. The batch se-
quence submission tool is automatically coupled to the
UCSC BLAT service with standard parameters (http://
genome.ucsc.edu/) to determine the best alignment and
genomic location for each insert. When there are mul-
tiple good alignments, user intervention is possible to
select the best genomic location. An input form is then
populated for the aligned sequence along with anyFigure 3 Searching the TRACER database. (A) TRACER lines can be retrie
insertion as defined by a genomic range or a region around a particular ge
specify stage and expression domains of interest. (B) Alternatively (“Visual s
visualised, and those within the range defined by a dragable and expandaexisting data for the line. A similar batch upload inter-
face exists for the parsing of the expression image and
annotation files. Internal users can also edit annotations
for existing lines using a separate curation interface.
Many of the interfaces utilise a controlled vocabulary
of terms to populate the drop-down menus, reducing
the number of typos in the database and preserving the
integrity of the data stored in TRACER. An administra-
tive database exists to edit these controlled vocabularies.
The external interface allows users to register interest
in particular lines, or - if the user’s genomic region of
interest is not yet covered - to wish for such a line when
it becomes available. These requests are captured in the
database and matching lines are displayed for the cura-
tors so they can contact the requesting researcher. For
user-defined regions of interest, new matching lines areved (“General search”) either based the genomic position of the
ne, or using the result of the expression assays, with the possibility to
earch”), the distribution of insertion sites along a chromosome is
ble red rectangle will be returned.
Figure 4 (See legend on next page.)
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Figure 4 Presentation of TRACER data. (A) Summary display of results for a TRACER search. For each line the TRACER name, genomic position,
orientation of the loxP site, summary of expression (expressed/positive, not expressed/negative, not done; developmental stage(s) assayed), status
(alive, cryopreserved, not maintained, newly created) and the transposon type are displayed. The final two columns allow users to select the data
for download, or to register interest in the line. Clicking on the “open” icon gives access to the detailed information of an insertion of interest.
Quick access to a thumbnail photo of a representative embryo and to the corresponding transposon is possible by a simple click on the
corresponding zone (B) Detailed view of a TRACER mouse line. The top section reveals basic information about the insertion, including the type
of insertion, the name of the parent insertion, the orientation of the loxP site and a visual representation of the transposon in the correct
orientation. The first panel shows the genomic context of the insertion in a snapshot from the Ensembl genome browser (Ensembl Genomic
view +/−0.5 Mb) along with links to view the insertion point in the Ensembl or UCSC genome browsers. The second panel shows photos and
annotations of the expression patterns of the regulatory sensor. The images can be mouse-overed to reveal a high-resolution zoomed-in view,
and the annotation of expression domains is displayed. The third panel shows information related to mapping and genotyping, including the
sequence obtained from the mapping procedure, and the sequences of the primers used to genotype animals carrying this specific insertion. The
interface in the panel on the left allows neighbouring insertions to be selected for detailed analysis of a region’s regulatory potential.
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through the curator interface.Utility
Searching the TRACER database
The “Browse the TRACER database” tab takes users to
the main search interface of the website (Figure 3A). In-
sertions of interest can be identified by a variety of op-
tions. For genome-centric views, a genomic region of
interest can be specified, defined either by chromosomal
coordinates (reference genome is MGSCv37/mm9), or
by a gene name (“associated gene name” from Ensembl
database) and an optional user-defined flanking region
(default is 0.5 Mb). In addition to this “General” option,
one can perform a “Visual” search by clicking on the link
at the top of the search window (Figure 3B). Users can
view the distribution of insertions across each chromo-
some and drag a rectangle to define the region they want
to retrieve lines. Searches can also be carried out based
on expression patterns, using criteria such as positive/
negative, expression domains and expression stages. The
label “negative” for expression means that no specific ex-
pression patterns was scored for this insertion at the em-
bryonic stages assayed, whereas an insertion is labelled
as “positive” if specific expression is detected at least at
one stage of development. The majority of the insertions
have been assayed at E11.5, but some data is available
at other stages (E10 to E13). Expression domains are
annotated using a simplified controlled vocabulary (e.g.
branchial arches, cranial ganglia, digestive, dorsal root
ganglia, ear, eye, face, forebrain, genital bud, heart, hind-
brain, limb, midbrain, neural tube, somites, urogenital,
others or widespread), which is compatible with the one
used by the Vista Enhancer Database [28], in order to
facilitate comparison of the two datasets.Display and download of data
Results are returned as a table (Figure 4A) with one row
per insertion and sortable columns displaying: The internal identifier of the mouse line in the
TRACER database.
 The genomic position of the insertion (chr/position ;
based on MGSCv37/mm9 genome assembly).
 The orientation of the loxP site in the transposon.
“Plus” corresponds to the following orientation:
centromere – 50-ATAACTTCGTATA
GCATACATTATACGAAGTTAT- 30 telomere. For
comparison, loxP sites targeted by the International
Knockout Mouse Consortium in genes transcribed
from the plus strand (http://www.knockoutmouse.
org/about/targeting-strategies) have the same
orientation than TRACER “plus” loxP. Depending on
the specific transposon, the orientation of the other
features (transposon ends, reporter gene) varies:
they are indicated and represented in the expanded
view available by clicking on the “expand” icon.
 An icon and text, indicating whether expression
analysis has been performed and whether LacZ
reporter expression has been detected. The
developmental stage(s) for which information is
available are indicated in the next column.
Expression assay is “positive” if the insertion showed
LacZ staining at least at one of the stages assessed.
 The status of the insertion, indicating whether
animals carrying the insertion are available.
Insertions that were identified in F0 embryos, that
couldn’t be established from the founder or were
discontinued, are labelled as “not maintained”.
Insertions “available” for further use or analysis fall
under three categories: “alive” (line established with
mice available in small numbers), “cryopreserved”
(either as embryos or sperm) and “new” (usually
corresponding to a new insertion, with only the
founder animal). The status of an insertion is
dynamic: not all “new” insertions are established,
and depending on circumstances, “alive” ones may
become “cryopreserved” or “not maintained”.
 Transposon type: most of the available lines harbour
a simple regulatory sensor with a lacZ reporter and
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relative to the transposon ends (SB8 and SB9). New
transposons with additional features have been
constructed (see Figure 2), and lines containing
them are being established and will be added to the
resource. Detailed maps and sequences of available
transposons are available on the Tracer website.
The final two columns display a checkbox to download
the complete set of information available for an inser-
tion, and an email link to indicate interest in a specific
insertion. The toolbar buttons above the results table
can be used to filter the search results, and to show only
available lines and/or lines with expression data.
Further details on a given insertion can be seen by
clicking the expand icon next to each record (Figure 4B).
The first section describes the genomic context of the
insertion. It lists whether the insertion is located in a
gene desert (a gene-free region larger than 500 kb),
intergenic (less than 500 kb-long), intronic or exonic re-
gion, specifies the orientation of the reporter gene, and
the parental insertion line from which the insertion was
obtained. This section also contains a schematic of the
transposon construct, the genomic environment and
flanking genes in a snapshot from the Ensembl genome
browser [51] along with links to view the insertion point
in Ensembl or the UCSC genome browser [52].
The second section shows the LacZ expression pat-
terns obtained for the insertion, when available. Mousing
over each thumbnail image show a zoomed-in, trackable
high-resolution view of the image. In addition, the stage
and viewpoint of the image is recorded along with anno-
tations using the expression domain categories detailed
above. One can switch from one image to another one
by clicking on the corresponding thumbnail.
The final section shows details regarding how the gen-
omic position of the insertion was determined, such as
the flanking sequence(s) obtained (trimmed to the TA
dinucleotide duplicated upon Sleeping Beauty insertion
[53]), and where this sequence mapped where this se-
quence mapped to genome using BLAT [54]. When
available, primers that have been used to genotype em-
bryos and mice for this specific insertion are indicated.
The left hand panel of the expanded section contains
an interface that displays lines with insertion points
within 5 Mb (or a user-selected range) (Figure 4B). Users
can select one or more of these lines, and open a new
tab displaying these flanking lines. This feature is par-
ticularly useful to compare regulatory activities across
large regions, and to delineate the extent of regulatory
domains.
Finally, the toolbar below the search interface allows
data to be downloaded for the whole TRACER database,
the search results, user selected lines or just the linesdescribed in publications referring to the dataset. Add-
itionally, all available images can be downloaded. Re-
quests for higher resolution photos and other questions
can be sent to gromit@embl.de. Most LacZ stained em-
bryos has been archived, albeit in limited numbers for
each insertion, and may be made available upon request.
User wish list
Although the TRACER database already covers a sub-
stantial proportion of the genome, it is likely that indi-
vidual researchers will be interested to get information
and mice with transposons in regions where we haven’t
yet identified an insertion. Given the high efficiency of
transposition, the number of new insertions identified in
on-going remobilisation efforts (~ 10 per week) exceeds
our current capacity to keep, expand and cryopreserve
all of them (Figure 5). The “User wish list” tab allows
scientists to indicate particular genomic regions they are
interested in, along with their contact details (Figure 5C).
Once an insertion in this region is identified, it is
“flagged” for the producing group, so that the corre-
sponding animal is kept, and the interested group will be
contacted.
Discussion
A functional view of the genome with TRACER
The introduction of a “regulatory sensor” in the genome
provides a direct operational readout of the activities
that can contribute to gene expression, which surround
the insertion point. Similar enhancer-trap screens have
widely been used in Drosophila [41] and to some extent
in zebrafish [55-58], providing information about genes
and genomes, as well as a series of useful markers and
tools. Their use in mice has been limited [59,60], in part
due to the low throughput of transgenesis, and technical
difficulties of generating single-copy insertions. The de-
velopment of robust and efficient in vivo transposition
systems [2,61-63], as shown here, or the use of lentiviral
transgenesis, as recently described elsewhere [64], open
new exciting possibilities to conduct such screens in an
efficient and affordable manner.
Collections of insertions generated by these ap-
proaches can provide useful information and tools, and
the TRACER database represents a substantial step to
capitalise on such a collection, by centralizing and giving
access to data and to mouse lines. We present and dis-
cuss here briefly some of the possible uses of this data-
base and of the information therein (Figure 6).
By querying the database for a gene or a region of
interest, one can identify expression patterns and regula-
tory activities associated with that location and its sur-
roundings. The observed activity may indicate possible
developmental or tissue-specific regulation of genes, and
shed light on their physiological roles in vivo (Figure 6A).
Figure 5 Evolution of TRACER dataset. (A) Genomic distribution of the insertions with expression annotations (red) and available as lines (blue)
(generated with the Karyoview tool from Ensembl – status in July 2012). Insertions on the Y chromosome are not shown as their positions are
ambiguous (B) The number of mapped insertions increases at a regular pace (light blue line), almost paralleled by expression reports (red cursor).
A smaller proportion of these are kept alive or archived by cryopreservation (blue cursor). (C) The user wish list allows researchers to register
interest for a genomic interval. It ensures that mice with new insertions in this region will be preserved for the scientist who indicated this
request. The interval of interest can be defined by position or by gene name.
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sor sometimes reflects only a subset of the expression
domains of a given gene [2]. Although the sensor re-
sponds accurately to influences from long-range remote
enhancers, it is less likely to capture the input of pro-
moter elements that have a limited range of action:
tissue-restricted expression of the sensor may therefore
represent a tissue-specific modulation of an otherwise
broadly expressed gene; yet, this modulation may corres-
pond to important biological functions.
Also, the expression pattern associated with an inser-
tion does not necessarily imply that a corresponding
enhancer lies nearby, as illustrated by the shared expres-
sion of distant insertions (Figure 6A,C; other examples
in [2]). Instead, the sensor reports the collective input at
a given position of both positive and negative regulatoryelements. Accordingly, comparing the expression pattern
of neighbouring insertions to each other and to known
enhancer activities [21,65] can reveal important regula-
tory features. These include the range of action of
enhancers, the boundaries of expression domains, the
presence of silencers or other repressive or insulating
elements that modulate enhancer activity and cannot be
obtained from other types of datasets and approaches. In
essence, TRACER provides an operational view of the
regulatory structure of the mammalian genome, and de-
lineates the extent of the large regulatory landscapes [6]
that subdivide the genome into functional units. It con-
stitutes a functional counterpart to views obtained by
different methods; including, for example, Genome Regu-
latory Blocks that are delineated by the density of con-
served non-coding elements and synteny conservation
Figure 6 Examples of potential applications of TRACER. (A) Using TRACER to obtain information about the regulatory potential of a specific
interval. Two loci (Ndst3 and Zfhx3) are given as an example, with photos of lacZ-stained embryos with insertions close or far from these genes.
(B) Searching TRACER for insertions with specific expression patterns can identify genomic positions where an inserted transgene will display a
predicted activity. Three insertions with different patterns of expression in the fronto-nasal process are shown as examples. Such specific patterns
can subsequently be exploited to re-target other transgenes with expression in the predicted domains through different techniques. (C)
Overlapping deletions (red bars) and duplications (blue bars) over 14q12 entered in the DECIPHER database (http://decipher.sanger.ac.uk/) are
associated with similar clinical phenotypes. TRACER insertions in the orthologous interval show that it corresponds to a large regulatory landscape
associated with forebrain (green) and facial (brown) expression domains in E11.5 (SB-202250e1 and SB-202250) and E12.5 (SB-177175emb7)
mouse embryos. LacZ expression in the ear of embryo SB-177175emb7 (star) is due to the presence of an additional insertion, SBlacC [2].
Enhancer regions (ovals, color-coded depending on their pattern of activity as shown in the schematized embryo; data from VISTA enhancer
browser [28]) present in the proximity may contribute to these activities. By local remobilisation and Cre-mediated recombineering, the mouse
line SB-202250 may be used to produce mouse models of the human aneuploidies associated with this largely non-coding interval.
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chromosomal interaction biases [68,69], and Enhancer-
Promoter Units that are revealed by clusters of coinci-
dent promoter-enhancer chromatin signatures [70].
The data present in TRACER identifies genomic posi-
tions where an inserted transgene will adopt a highly
specific expression profile (Figure 6B). Transgenes that
drive the expression of markers to label specific cells
(such as fluorescent markers) or of effector genes (for
example Cre recombinase) in defined cell-types or
embryonic tissues have proven very useful to dissect bio-
logical and genetic processes. “Position-effects” (the ac-
tion of endogenous regulatory elements on transgenes)
are usually considered as a problem for transgenic ex-
periments because they lead to partially unpredictable
outcomes. With the information displayed in TRACER,
one can instead exploit position effects, and select gen-
omic sites that will convey an expression pattern of inter-
est. Importantly, many of these sites are located far from
genes, implying that their use would have less functional
impact than a gene knock-in. The sensor integrates the in-
puts of both enhancers and silencers that are acting at its
position: consequently, the observed pattern is often more
restricted than the one driven by enhancer-only constructs
or displayed by the neighbouring genes [2]. Hence,
retargeting positions identified in TRACER with a trans-
gene of interest should provide a reliable method to create
new tissue- and cell-type specific transgenes. This can be
done by homologous recombination in mouse ES cells,
but the rapid development of Zinc-Finger or TALE
Nuclease-associated targeted transgenesis may offer more
efficient alternatives [46,71,72].
In addition to maps of genomic “regulatory land-
scapes”, TRACER provides access to a large and growing
collection of mice with different transposon insertions
(around 200 in July 2012). Only few insertions are likely
to disrupt genes or key/highly conserved regulatory ele-
ments directly. Instead, these mice can be used for other
purposes, and in particular for engineering aneuploidies
and structural variants. Chromosomal aneuploidies are
often found in patients suffering developmental malfor-
mations and/or neuropsychiatric disorders. In some
cases, single gene-knockout can reproduce the pheno-
types observed in human patients; however, for numer-
ous other conditions, such as contiguous gene diseases,
chromosomal duplications or rearrangements in non-
coding intervals, gene-based alleles do not provide ac-
curate models. Because Sleeping Beauty transposons
frequently re-insert in the vicinity of their initial pos-
ition, it is possible to use one insertion in a region of
interest to generate additional local re-insertions. These
insertions can be (re)combined owing to the associated
loxP sites, to produce a series of rearrangements of this
locus that model genomic alterations found in humanpatients, and help determine the causal elements or
genes (Figure 6C). Such a use of the TRACER resource
and GROMIT strategy can be particularly well suited for
large gene clusters (eg. proto-cadherins, KRAB-zinc fin-
ger genes, olfactory receptors) or gene-deserts associated
with human pathologies, complementing the gene-
centric resource provided by the International Knockout
Mouse Consortium. Given the growing recognition of
the biological importance of genomic structural variants
for human diseases, we anticipate that TRACER will be
a useful resource to rapidly engineer allelic series of
structural variants in mouse orthologous intervals, help-
ing to create novel models of human genomic disorders.
Conclusion
TRACER database and community
Owing to the dynamic nature of transposon elements, the
resource present in TRACER will expand steadily with the
number of users. Each lab using this transposon technol-
ogy to investigate a region of interest by “local” hopping
will produce a substantial number of by-products (~ 80%
of the new insertions). Even if these insertions may not be
useful for the producing lab, they can be of interest for
others. TRACER is designed to serve as a central “virtual”
repository to share those mice. Further information, in-
cluding references, detailed maps and sequences of the
different transposons and transgenes in use, and protocols
for mapping of new insertions are available through the
pages of the TRACER website.
To facilitate exchanges, the TRACER database incor-
porates several features and internal interfaces for
contributing groups (automated insertion mapping, an-
notation and administration). In particular, the “User
wish list” feature offers a simple manner to readily “tag”
newly generated mice of interest without a major invest-
ment or commitment of the producing labs.
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